List of Tables
Table 1. Global Kidney Transplant Anti-Rejection Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Kidney Transplant Anti-Rejection Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Kidney Transplant Anti-Rejection Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Kidney Transplant Anti-Rejection Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Kidney Transplant Anti-Rejection Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Kidney Transplant Anti-Rejection Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Kidney Transplant Anti-Rejection Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Kidney Transplant Anti-Rejection Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Kidney Transplant Anti-Rejection Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Kidney Transplant Anti-Rejection Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Kidney Transplant Anti-Rejection Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Kidney Transplant Anti-Rejection Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Kidney Transplant Anti-Rejection Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Transplant Anti-Rejection Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Kidney Transplant Anti-Rejection Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Kidney Transplant Anti-Rejection Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Kidney Transplant Anti-Rejection Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Kidney Transplant Anti-Rejection Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Kidney Transplant Anti-Rejection Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Kidney Transplant Anti-Rejection Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Kidney Transplant Anti-Rejection Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Kidney Transplant Anti-Rejection Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Kidney Transplant Anti-Rejection Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Kidney Transplant Anti-Rejection Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Kidney Transplant Anti-Rejection Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Kidney Transplant Anti-Rejection Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Kidney Transplant Anti-Rejection Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Kidney Transplant Anti-Rejection Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Kidney Transplant Anti-Rejection Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Kidney Transplant Anti-Rejection Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Kidney Transplant Anti-Rejection Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Kidney Transplant Anti-Rejection Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Kidney Transplant Anti-Rejection Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Kidney Transplant Anti-Rejection Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Kidney Transplant Anti-Rejection Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Kidney Transplant Anti-Rejection Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Kidney Transplant Anti-Rejection Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Kidney Transplant Anti-Rejection Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Kidney Transplant Anti-Rejection Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Kidney Transplant Anti-Rejection Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Kidney Transplant Anti-Rejection Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Kidney Transplant Anti-Rejection Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Kidney Transplant Anti-Rejection Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Kidney Transplant Anti-Rejection Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Kidney Transplant Anti-Rejection Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Kidney Transplant Anti-Rejection Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Kidney Transplant Anti-Rejection Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Kidney Transplant Anti-Rejection Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Kidney Transplant Anti-Rejection Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Kidney Transplant Anti-Rejection Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Kidney Transplant Anti-Rejection Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Kidney Transplant Anti-Rejection Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Kidney Transplant Anti-Rejection Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Kidney Transplant Anti-Rejection Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Kidney Transplant Anti-Rejection Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Kidney Transplant Anti-Rejection Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Kidney Transplant Anti-Rejection Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Kidney Transplant Anti-Rejection Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Kidney Transplant Anti-Rejection Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Kidney Transplant Anti-Rejection Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Kidney Transplant Anti-Rejection Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Kidney Transplant Anti-Rejection Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Kidney Transplant Anti-Rejection Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Kidney Transplant Anti-Rejection Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Kidney Transplant Anti-Rejection Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Kidney Transplant Anti-Rejection Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Kidney Transplant Anti-Rejection Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Kidney Transplant Anti-Rejection Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Kidney Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Roche Kidney Transplant Anti-Rejection Drugs Product
Table 74. Roche Recent Developments/Updates
Table 75. Astellas Pharma Inc. Company Information
Table 76. Astellas Pharma Inc. Description and Business Overview
Table 77. Astellas Pharma Inc. Kidney Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Astellas Pharma Inc. Kidney Transplant Anti-Rejection Drugs Product
Table 79. Astellas Pharma Inc. Recent Developments/Updates
Table 80. Sanofi Genzyme Company Information
Table 81. Sanofi Genzyme Description and Business Overview
Table 82. Sanofi Genzyme Kidney Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Sanofi Genzyme Kidney Transplant Anti-Rejection Drugs Product
Table 84. Sanofi Genzyme Recent Developments/Updates
Table 85. Novartis Company Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Kidney Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Novartis Kidney Transplant Anti-Rejection Drugs Product
Table 89. Novartis Recent Developments/Updates
Table 90. Asahi Kasei Corporation(Veloxis Pharmaceuticals) Company Information
Table 91. Asahi Kasei Corporation(Veloxis Pharmaceuticals) Description and Business Overview
Table 92. Asahi Kasei Corporation(Veloxis Pharmaceuticals) Kidney Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Asahi Kasei Corporation(Veloxis Pharmaceuticals) Kidney Transplant Anti-Rejection Drugs Product
Table 94. Asahi Kasei Corporation(Veloxis Pharmaceuticals) Recent Developments/Updates
Table 95. Wyeth Company Information
Table 96. Wyeth Description and Business Overview
Table 97. Wyeth Kidney Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Wyeth Kidney Transplant Anti-Rejection Drugs Product
Table 99. Wyeth Recent Developments/Updates
Table 100. Bristol-Myers Squibb Company Company Information
Table 101. Bristol-Myers Squibb Company Description and Business Overview
Table 102. Bristol-Myers Squibb Company Kidney Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Bristol-Myers Squibb Company Kidney Transplant Anti-Rejection Drugs Product
Table 104. Bristol-Myers Squibb Company Recent Developments/Updates
Table 105. Nippon Kayaku Company Information
Table 106. Nippon Kayaku Description and Business Overview
Table 107. Nippon Kayaku Kidney Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Nippon Kayaku Kidney Transplant Anti-Rejection Drugs Product
Table 109. Nippon Kayaku Recent Developments/Updates
Table 110. Pfizer Company Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer Kidney Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Pfizer Kidney Transplant Anti-Rejection Drugs Product
Table 114. Pfizer Recent Developments/Updates
Table 115. Hansa Biopharma Company Information
Table 116. Hansa Biopharma Description and Business Overview
Table 117. Hansa Biopharma Kidney Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Hansa Biopharma Kidney Transplant Anti-Rejection Drugs Product
Table 119. Hansa Biopharma Recent Developments/Updates
Table 120. GSK Company Information
Table 121. GSK Description and Business Overview
Table 122. GSK Kidney Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. GSK Kidney Transplant Anti-Rejection Drugs Product
Table 124. GSK Recent Developments/Updates
Table 125. AbbVie Company Information
Table 126. AbbVie Description and Business Overview
Table 127. AbbVie Kidney Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. AbbVie Kidney Transplant Anti-Rejection Drugs Product
Table 129. AbbVie Recent Developments/Updates
Table 130. Huadong Medicine Company Information
Table 131. Huadong Medicine Description and Business Overview
Table 132. Huadong Medicine Kidney Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Huadong Medicine Kidney Transplant Anti-Rejection Drugs Product
Table 134. Huadong Medicine Recent Developments/Updates
Table 135. North China Pharmaceutical Group Company Information
Table 136. North China Pharmaceutical Group Description and Business Overview
Table 137. North China Pharmaceutical Group Kidney Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. North China Pharmaceutical Group Kidney Transplant Anti-Rejection Drugs Product
Table 139. North China Pharmaceutical Group Recent Developments/Updates
Table 140. Beijing SL Pharmaceutical Company Information
Table 141. Beijing SL Pharmaceutical Description and Business Overview
Table 142. Beijing SL Pharmaceutical Kidney Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Beijing SL Pharmaceutical Kidney Transplant Anti-Rejection Drugs Product
Table 144. Beijing SL Pharmaceutical Recent Developments/Updates
Table 145. Livzon Pharm Company Information
Table 146. Livzon Pharm Description and Business Overview
Table 147. Livzon Pharm Kidney Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Livzon Pharm Kidney Transplant Anti-Rejection Drugs Product
Table 149. Livzon Pharm Recent Developments/Updates
Table 150. Ruibang Pharmaceutical Company Information
Table 151. Ruibang Pharmaceutical Description and Business Overview
Table 152. Ruibang Pharmaceutical Kidney Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Ruibang Pharmaceutical Kidney Transplant Anti-Rejection Drugs Product
Table 154. Ruibang Pharmaceutical Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Kidney Transplant Anti-Rejection Drugs Distributors List
Table 158. Kidney Transplant Anti-Rejection Drugs Customers List
Table 159. Kidney Transplant Anti-Rejection Drugs Market Trends
Table 160. Kidney Transplant Anti-Rejection Drugs Market Drivers
Table 161. Kidney Transplant Anti-Rejection Drugs Market Challenges
Table 162. Kidney Transplant Anti-Rejection Drugs Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Kidney Transplant Anti-Rejection Drugs
Figure 2. Global Kidney Transplant Anti-Rejection Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Kidney Transplant Anti-Rejection Drugs Market Share by Type: 2024 & 2031
Figure 4. Calmodulin Inhibitor Product Picture
Figure 5. Antimetabolites Product Picture
Figure 6. Glucocorticoids Product Picture
Figure 7. Anti-Angiogenic Drugs Product Picture
Figure 8. Immune Inducing Drugs Product Picture
Figure 9. Global Kidney Transplant Anti-Rejection Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Kidney Transplant Anti-Rejection Drugs Market Share by Application: 2024 & 2031
Figure 11. Hospital
Figure 12. Pharmacy
Figure 13. Online Sales
Figure 14. Medical Institutions
Figure 15. Global Kidney Transplant Anti-Rejection Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Kidney Transplant Anti-Rejection Drugs Market Size (2020-2031) & (US$ Million)
Figure 17. Global Kidney Transplant Anti-Rejection Drugs Sales (2020-2031) & (K Units)
Figure 18. Global Kidney Transplant Anti-Rejection Drugs Average Price (US$/Unit) & (2020-2031)
Figure 19. Kidney Transplant Anti-Rejection Drugs Report Years Considered
Figure 20. Kidney Transplant Anti-Rejection Drugs Sales Share by Manufacturers in 2024
Figure 21. Global Kidney Transplant Anti-Rejection Drugs Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Kidney Transplant Anti-Rejection Drugs Players: Market Share by Revenue in Kidney Transplant Anti-Rejection Drugs in 2024
Figure 23. Kidney Transplant Anti-Rejection Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Kidney Transplant Anti-Rejection Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Kidney Transplant Anti-Rejection Drugs Sales Market Share by Country (2020-2031)
Figure 26. North America Kidney Transplant Anti-Rejection Drugs Revenue Market Share by Country (2020-2031)
Figure 27. United States Kidney Transplant Anti-Rejection Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Kidney Transplant Anti-Rejection Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Kidney Transplant Anti-Rejection Drugs Sales Market Share by Country (2020-2031)
Figure 30. Europe Kidney Transplant Anti-Rejection Drugs Revenue Market Share by Country (2020-2031)
Figure 31. Germany Kidney Transplant Anti-Rejection Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Kidney Transplant Anti-Rejection Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Kidney Transplant Anti-Rejection Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Kidney Transplant Anti-Rejection Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Kidney Transplant Anti-Rejection Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Kidney Transplant Anti-Rejection Drugs Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Kidney Transplant Anti-Rejection Drugs Revenue Market Share by Region (2020-2031)
Figure 38. China Kidney Transplant Anti-Rejection Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Kidney Transplant Anti-Rejection Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Kidney Transplant Anti-Rejection Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Kidney Transplant Anti-Rejection Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Kidney Transplant Anti-Rejection Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. China Taiwan Kidney Transplant Anti-Rejection Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Kidney Transplant Anti-Rejection Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Kidney Transplant Anti-Rejection Drugs Sales Market Share by Country (2020-2031)
Figure 46. Latin America Kidney Transplant Anti-Rejection Drugs Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Kidney Transplant Anti-Rejection Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Kidney Transplant Anti-Rejection Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Kidney Transplant Anti-Rejection Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Kidney Transplant Anti-Rejection Drugs Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Kidney Transplant Anti-Rejection Drugs Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Kidney Transplant Anti-Rejection Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Kidney Transplant Anti-Rejection Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Kidney Transplant Anti-Rejection Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Kidney Transplant Anti-Rejection Drugs by Type (2020-2031)
Figure 56. Global Revenue Market Share of Kidney Transplant Anti-Rejection Drugs by Type (2020-2031)
Figure 57. Global Kidney Transplant Anti-Rejection Drugs Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Kidney Transplant Anti-Rejection Drugs by Application (2020-2031)
Figure 59. Global Revenue Market Share of Kidney Transplant Anti-Rejection Drugs by Application (2020-2031)
Figure 60. Global Kidney Transplant Anti-Rejection Drugs Price (US$/Unit) by Application (2020-2031)
Figure 61. Kidney Transplant Anti-Rejection Drugs Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
